<code id='F9D35DBCEC'></code><style id='F9D35DBCEC'></style>
      • <acronym id='F9D35DBCEC'></acronym>
      <center id='F9D35DBCEC'><center id='F9D35DBCEC'><tfoot id='F9D35DBCEC'></tfoot></center><abbr id='F9D35DBCEC'><dir id='F9D35DBCEC'><tfoot id='F9D35DBCEC'></tfoot><noframes id='F9D35DBCEC'>
      • <optgroup id='F9D35DBCEC'><strike id='F9D35DBCEC'><sup id='F9D35DBCEC'></sup></strike><code id='F9D35DBCEC'></code></optgroup>
        5. <b id='F9D35DBCEC'><label id='F9D35DBCEC'><select id='F9D35DBCEC'><dt id='F9D35DBCEC'><span id='F9D35DBCEC'></span></dt></select></label></b><u id='F9D35DBCEC'></u>
          <i id='F9D35DBCEC'><strike id='F9D35DBCEC'><tt id='F9D35DBCEC'><pre id='F9D35DBCEC'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-09-06 06:51:03 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：fashion   
                                        
                                      
                                      Page View：967
                                  
                                    
          
                                   
          Alexis Borisy
          Venture capitalist Alexis Borisy																									Vanessa Leroy for STAT
          EQRx is done, sold for its cash.
          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.
          advertisement
          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          The (many) problems with a new study criticizing cancer screening
                                
                            
          Next article：  
                                      
                                          DIEP, the 'gold standard' of breast reconstruction, is under threat
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles